Retour
Fourchette du Jour
0,48 €
0,52 €
Fourchette 52 Semaines
0,46 €
0,88 €
Volume
2 100
Moyenne 50J / 200J
0,56 €
/
0,58 €
Clôture Précédente
0,48 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 7,2 | 0,4 |
| P/B | 0,2 | 2,9 |
| ROE % | 2,5 | 3,7 |
| Net Margin % | 3,8 | 3,9 |
| Rev Growth 5Y % | -32,0 | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,00 €
0,00 € – 0,00 €
|
4,4 B | 0 |
| FY2026 |
0,00 €
0,00 € – 0,00 €
|
4,1 B | 0 |
Points Clés
Revenue declined -32,04% annually over 5 years
ROE of 2,50% is below average
Debt/Equity of 0,18 — conservative balance sheet
Generating 156,31M in free cash flow
P/E of 7,22 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 70,82%
Croissance
Revenue Growth (5Y)
-32,04%
Revenue (1Y)38,78%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
2,50%
ROIC1,19%
Net Margin3,79%
Op. Margin2,55%
Sécurité
Debt / Equity
0,18
Current Ratio2,75
Interest Coverage17,42
Valorisation
P/E Ratio
7,22
P/B Ratio0,20
EV/EBITDA16,92
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 38,78% | Revenue Growth (3Y) | 24,33% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -32,04% | Earnings Growth (5Y) | -63,88% |
| Profitability | |||
| Revenue (TTM) | 3,49B | Net Income (TTM) | 132,18M |
| ROE | 2,50% | ROA | 2,11% |
| Gross Margin | 2,55% | Operating Margin | 2,55% |
| Net Margin | 3,79% | Free Cash Flow (TTM) | 156,31M |
| ROIC | 1,19% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,18 | Current Ratio | 2,75 |
| Interest Coverage | 17,42 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 7,22 | P/B Ratio | 0,20 |
| P/S Ratio | 0,27 | PEG Ratio | -0,16 |
| EV/EBITDA | 16,92 | Dividend Yield | 0,00% |
| Market Cap | 954,14M | Enterprise Value | 1,51B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,49B | 2,51B | 2,26B | 5,57B | 16,36B |
| Net Income | 132,18M | -18,27M | -878,61M | 275,73M | 7,76B |
| EPS (Diluted) | 0,05 | -0,03 | -0,48 | 0,11 | 3,84 |
| Gross Profit | 89,01M | 265,32M | 64,32M | 953,38M | 11,10B |
| Operating Income | 89,01M | -182,55M | -532,62M | 354,87M | 10,03B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6,27B | 6,96B | 7,06B | 8,12B | 9,78B |
| Total Liabilities | 1,49B | 1,12B | 1,14B | 1,32B | 2,56B |
| Shareholders' Equity | 4,76B | 5,81B | 5,89B | 6,75B | 7,17B |
| Total Debt | 849,86M | 422,09M | 581,85M | 417,07M | 482,38M |
| Cash & Equivalents | 298,39M | 282,84M | 279,77M | 433,44M | 875,20M |
| Current Assets | 1,45B | 1,83B | 1,69B | 2,11B | 4,35B |
| Current Liabilities | 528,78M | 949,80M | 923,87M | 996,49M | 2,20B |
Scores de Stratégies
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026